Medical Imaging Corporation (TPEX:6637)
Taiwan · Delayed Price · Currency is TWD 60.90
-0.10 (-0.16%)
Aug 19, 2026, 10:41 AM CST
Medical Imaging Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 915.34 | 1,164 | 829.03 | 682.18 | 487.29 | 604.12 | |
Revenue Growth | -24.93% | 40.45% | 21.52% | 40.00% | -19.34% | 10.66% |
Cost of Revenue | 613.98 | 813.95 | 492.93 | 353.86 | 247.79 | 377.02 |
Gross Profit | 301.37 | 350.43 | 336.09 | 328.32 | 239.51 | 227.1 |
Selling, General & Admin | 126.09 | 124.55 | 136.46 | 116.41 | 93.06 | 92.23 |
Operating Expenses | 126.12 | 124.51 | 136.42 | 116.66 | 93.11 | 92.36 |
Operating Income | 175.25 | 225.92 | 199.67 | 211.66 | 146.4 | 134.75 |
Interest Expense | -8.61 | -6.9 | -2.64 | -2.78 | -3.38 | -3.69 |
Interest & Investment Income | 16.54 | 11.75 | 5.24 | 2.13 | 2.18 | 2.8 |
Earnings From Equity Investments | - | - | - | - | 6.66 | -30.71 |
Currency Exchange Gain (Loss) | 3.04 | 3.04 | 0.48 | -0.01 | 1.66 | -0.08 |
Other Non Operating Income (Expenses) | -5.57 | 0.39 | -0.72 | -0.2 | -0.12 | -0.95 |
EBT Excluding Unusual Items | 180.65 | 234.19 | 202.04 | 210.8 | 153.39 | 102.12 |
Gain (Loss) on Sale of Investments | -2.88 | -2.88 | -1.99 | -43.06 | -10.12 | -5.68 |
Gain (Loss) on Sale of Assets | 5.02 | 5.02 | 8.33 | 0.75 | 1.24 | 1.65 |
Pretax Income | 182.79 | 236.33 | 208.38 | 168.49 | 144.5 | 98.09 |
Income Tax Expense | 35.3 | 50.79 | 43.36 | 47.15 | 32.9 | 21.32 |
Net Income | 147.49 | 185.54 | 165.02 | 121.34 | 111.6 | 76.78 |
Net Income to Common | 147.49 | 185.54 | 165.02 | 121.34 | 111.6 | 76.78 |
Net Income Growth | -23.64% | 12.44% | 36.00% | 8.72% | 45.36% | -20.07% |
Shares Outstanding (Basic) | 27 | 26 | 23 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 27 | 26 | 23 | 22 | 22 | 22 |
Shares Change | 8.99% | 12.51% | 7.38% | -0.07% | -0.01% | 0.12% |
EPS (Basic) | 5.50 | 7.17 | 7.17 | 5.66 | 5.20 | 3.58 |
EPS (Diluted) | 5.48 | 7.14 | 7.15 | 5.64 | 5.19 | 3.57 |
EPS Growth | -29.97% | -0.14% | 26.77% | 8.67% | 45.38% | -19.96% |
Free Cash Flow | -43.63 | -322.05 | 172.14 | 88.64 | 211.02 | 81.99 |
Free Cash Flow Per Share | -1.62 | -12.40 | 7.46 | 4.12 | 9.80 | 3.81 |
Dividend Per Share | 4.500 | 4.500 | 4.000 | 3.000 | 2.800 | 2.000 |
Dividend Growth | 12.50% | 12.50% | 33.33% | 7.14% | 40.00% | -20.00% |
Gross Margin | 32.92% | 30.10% | 40.54% | 48.13% | 49.15% | 37.59% |
Operating Margin | 19.15% | 19.40% | 24.09% | 31.03% | 30.04% | 22.30% |
Profit Margin | 16.11% | 15.93% | 19.91% | 17.79% | 22.90% | 12.71% |
Free Cash Flow Margin | -4.77% | -27.66% | 20.76% | 12.99% | 43.30% | 13.57% |
EBITDA | 228.19 | 275.44 | 248.76 | 252.56 | 197.45 | 188.89 |
EBITDA Margin | 24.93% | 23.66% | 30.01% | 37.02% | 40.52% | 31.27% |
D&A For EBITDA | 52.94 | 49.53 | 49.09 | 40.9 | 51.05 | 54.15 |
EBIT | 175.25 | 225.92 | 199.67 | 211.66 | 146.4 | 134.75 |
EBIT Margin | 19.15% | 19.40% | 24.09% | 31.03% | 30.04% | 22.30% |
Effective Tax Rate | 19.31% | 21.49% | 20.81% | 27.98% | 22.77% | 21.73% |